A glance back at some of the important ups and down Indian Inc faced in 2018.
Ambani is also the year's biggest gainer, adding USD 9.3 billion to his wealth amid the continuing success of his Reliance Jio broadband telco service.
Forbes said Prime Minister Narendra Modi's "economic experiments" barely affected India's billionaires while none gained more than oil-and-gas tycoon Mukesh Ambani, who cemented his decade-long hold on the top slot by adding a staggering USD 15.3 billion (67 per cent) to his last year's wealth to become one of Asia's top five richest.
Partnership between Israel and India is doing wonders, the visiting prime minister tells business leaders.
Jeff Bezos of Amazon tops the list for the second consecutive year with networth of $147 billion.
The deal will provide Suzlon with much needed liquidity.
Samvat 2070 was a great year for top Indian conglomerates in the stock markets.
Top ten billionaires in India.
India seeks greater market access for its products including textiles, pharmaceuticals and bovine meat.
Industrialist Mukesh Ambani remains India's richest person with a sharp surge of 30 per cent in his net worth to $26 billion.
Silverstreet Developers LLP, which had no holding in Ranbaxy at the end of September 2013, had bought shares of the Gurgaon-based firm aggregating 1.41 per cent stake by end of December 2013. As on March 31, 2014, its holding stood at 1.64 per cent.
Mukesh Ambani remains the country's wealthiest promoter as his stake in Reliance is now worth Rs 3.25 trillion!
The company will transfer its wallet business, which has over 218 million mobile wallet users, to the newly incorporated entity -- PPBL -- under the payments bank licence awarded to Vijay Shekhar Sharma, the founder of One97 Communications that owns Paytm.
Who is to take their place? Will a new generation of entrepreneurs start up with better business sense, or at least better luck? But the so-called unicorns are mostly copy-cat entrepreneurs whose cash flow is funded by overseas (including Chinese) money, notes T N Ninan.
The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.
India Inc is ready to diversify into unchartered areas.
As record stock market rally continues, the value of shares directly owned by next-generation business leaders at 20 major corporate houses has soared over 18 per cent to Rs 17,000 crore.
Few top honchos of India Inc did very well in 2014.
In the Forbes rich list Mukesh Ambani is ranked 39th.
Sun Pharma profit down 30% over compliance costs, lower sales.
The merger has fortified Sun Pharma's position.
The 20 richest people on the planet are worth a staggering USD 1.2 trillion, a sum roughly equivalent to the annual economic output of Mexico.
The total wealth of India's top five billionaires, which stands at a whopping $83.7 billion, is more than the cost of 1,230 Mars Orbiter 'Mangalyaan' Missions and is more than 18 times the cost of hosting the 2016 Rio Olympics
Last August, RBI gave in-principle approval to 11 applicants.
Netanyahu will cap his hectic schedule by attending the 'Shalom Bollywood' event.
.jpg)
Of the 11 licence holders, only eight remain in the fray as concerns about profitability and rising competition are making them think twice before jumping in.
Top 100 billionaires see their wealth rise 10%; top 20 account for half of total wealth of top 100.
Last year, the software giant launched a cloud adoption programme for SMBs.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.
No business delegation has been cleared yet for Prime Minister Narendra Modi 's visit to America from Friday.
President Pranab Mukherjee presented five Padma Vibhushan, eight Padma Bhushan and forty-three Padma Shri awards at the Rashtrapati Bhavan in New Delhi.
But splitting management bandwidth by investing in non-core businesses will not be appreciated by the market in the long run.
Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.
Five stocks - Havells, NCC, Suzlon, Blue Star and Crompton Greaves look most attractive after the recent course correction.
ICICI Bank and SBI were among the top Sensex gainers along with FMCG majors ITC and HUL.
Sources indicated defence and national security initiatives.
How Chanda Kochhar and her husband Deepak Kochhar find themselves in a huge controversy.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances